Southlake Psychiatry. Suboxone Contract
|
|
- Brett Gregory
- 7 years ago
- Views:
Transcription
1 Suboxone Contract Thank you for considering Southlake Psychiatry for your Suboxone treatment. Opiate Addiction is a serious condition for which you may find relief with Suboxone treatment. In order to increase your chance for successful treatment and due to the increased monitoring required by the DEA, we have found the following guidelines necessary for us to follow. Please read and sign the Suboxone contract, complete the opiate and other substance use questionnaire, complete the opiate use checklist, sign and date all areas requiring a signature and bring these to your initial interview. GENERAL 1. You must clearly understand, under no circumstances can you take your medication other than how it is prescribed. If the medication prescribed is not relieving your clinical symptoms, it is your responsibility to contact this practice and inform us, so we can instruct you on what you may do. If you do not adhere to this, you may be discharged from this practice or have your Suboxone dose reduced. 2. This practice will not prescribe any benzodiazepines to patients who are taking Suboxone. 3. If you lose your prescription, or for any reason your medication is misplaced, lost or even stolen, no substitute prescription will be provided. Understand that losing or misplacing a controlled prescription may have serious medical consequences, including withdrawal, even death. Please notify us if this occurs so we may assist you. Suspected misuse of Suboxone may result in being discharged from the practice. 4. All Suboxone patients will be using one pharmacy CVS, to fill their Suboxone prescriptions. You will need to provide us with the name and phone number of the CVS pharmacy you prefer. 5. All fees are due at the time of the visit with us, before seeing your medical provider. 6. All patients who are receiving prescribed Suboxone will be required to attend counseling with a licensed counselor. You are required to sign an Authorization to Disclose Information and provide the phone number of your counselor to allow unlimited communication between your medical provider here and your counselor. Please note HIPPA policy and procedures will apply. If you fail to cancel in time or fail to attend an appointment with your counselor, you may be discharged from this practice or have your Suboxone dose reduced. RANDOM URINE DRUG SCREENS 1. During the initial evaluation and at each successive follow up visit, patients who receive prescribed Suboxone will inform the medical provider of all medications or illicit drugs that have been taken over the past thirty days or between visits, whichever is longer. A form entitled Controlled Substances Check List will be provided for you to complete. Note, please take your time when completing this check list. If the drug screen identifies illicit drugs or prescribed medications that were not disclosed, you may be discharged from this practice or have your Suboxone dose reduced.
2 Suboxone Contract 2. You are required to submit to Random Drug Screening performed by LabCorp and/or Southlake Psychiatry. This will be done at the discretion of your medical provider. You are responsible for all fees associated with the Drug Screening. You are responsible for locating a LabCorp convenient for you, and for providing us the address and phone number of that LabCorp location. You will be notified by phone of the need to get the urine drug screen and will be required to present within four hours to your LabCorp location. If for some reason, you are unable to perform the urine drug screen in time, you must provide written reason why you were unable to do so and you may be discharged from this practice or have your Suboxone dose reduced. 3. Please understand, Suboxone will not be a medication of dependency and therefore Suboxone will replace taking any other opiates. Discussion about stopping Suboxone will be initiated at your first evaluation and with your first dose of this medication. Reduction of dosing will be performed in a manner to minimize the risk of withdrawal symptoms. If you have fears and reluctance regarding reduction of your Suboxone this matter must be discussed with your Counselor (see below for responsibilities regarding counseling). 4. If this practice is prescribing Suboxone and this medication is not identified through random drug screening you will be discharged from this practice immediately. OFFICE APPOINTMENTS WITH SOUTHLAKE PSYCHIATRY 1. If you need to cancel your appointment with us, it is our practice policy that you call 24 hours prior to your scheduled appointment. If you fail to cancel in time or fail to attend an appointment with your medical provider, you will be charged for the appointment, and you may be discharged from this practice or have your Suboxone dose reduced. 2. If you have a justifiable reason for cancelling within the 24 hour period or missing an appointment, you must provide us in writing the reason you were unable to your counselor or medical provider. If you were ill you must provide a written medical excuse from the medical provider you saw. Signing below indicates that you understand of this treatment contract and you agree to adhere to all the above requirements. Name Date of Birth Signature Date
3 Opiate and other Substance Use Questionnaire When was the very first day that you ever took an opiate? What was the reason? (circle one): Experimental, Recreational, Pain management (prescribed), pain management (not prescribed) What opiate did you first take? (circle one): Hydrocodone, Oxycodone, Heroin, Fentanyl, Methadone Other (describe): Which opiates have you used regularly, How many years have you taken opiates? Did you ever have a period of time when you were able to stop taking opiates? (circle one): Yes / No and What is the longest a period of abstinence you ve had? What route of administration did you prefer? (circle one): Oral, Injection, Inhalation In the space provided below please list and describe any other controlled substances you have used, including alcohol. Use of any controlled substances (prescribed or illicit) other than Suboxone such as Benzodiazepines, stimulants, alcohol, marijuana, and cocaine use is prohibited while receiving prescribed Suboxone. Please anticipate that any information listed here will be shared with your substance abuse counselor to aid your recovery. 1) Substance (Alcohol) Last used Amount Route of administration (oral) 2) Substance Last used Have you ever had a period of abstinence from this? (circle one) Yes/No How long?
4 Opiate and other Substance Use Questionnaire 3) Substance Last used 4) Substance Last used 5) Substance Last used 6) Substance Last used *Please fill out more copies of this page if you have additional substances to list. **Please note random drug screening will be required at the discretion of your medical provider, see Suboxone contract for details
5 Opiate and other Substance Use Questionnaire Important information you need to know and/or bring prior to your first, initial visit: Insurance Coverage: Insurance companies require certain criteria which must be met and maintained in order to cover your visits and your Suboxone. The criteria usually include the following and possibly other criteria. It is your responsibility to contact your insurance company and seek out this information. Please provide your Insurance information to the office prior to your visit so we may verify your Insurance, bring your Insurance card with you to your office visits. Please see our practice Financial Agreement for additional information. 1. The individual must be opiate dependent 2. The individual must receive Suboxone from a physician who has the DEA # specific to Suboxone prescribing 3. The individual must be involved in substance abuse counseling; this is also a requirement of this practice 4. The individual must abstain from any other opiate use Important information you need bring with you to your first appointment: 1. CVS (800) will be the only pharmacy utilized in dispensing Suboxone; write the phone number for the CVS convenient to you. 2. LabCorp (800) will be the only lab where urine drug screening will take place. Write the phone number and location of the LabCorp where you can present within 4 hours of being instructed to obtain a Random Drug Screen. Phone# Location 3. It is your responsibility to have a working cell phone so that we may contact you, and to update your phone number with us should it change. 4. At the time of initial evaluation please provide either your NC driver's license or approved NC identification. 5. You must inform us of any change in address. Signature: Date: Name DOB
6 Suboxone Contract Prevention of Suboxone induced withdrawal symptoms is the primary reason for the waiting period after stopping other opiates and before starting Suboxone. Starting Suboxone may cause opiate withdrawal if taken too soon after your last opiate use. Therefore it is imperative that you accurately report your last opiate use. Recommended wait time between last opiate use and starting Suboxone Dilaudid 12 to 24 hours Fentanyl 48 to 72 hours after patch removal Heroin 12 to 24 hours Hydrocodone 12 to 24 hours Methadone 72 to 96 hours Morphine 12 to 24 hours Oxycodone 48 to 72 hours Opiate used Date, amount, and last time used (circle all that apply) Dilaudid Fentanyl Heroin Hydrocodone Methadone Morphine Oxycodone Other Signature Date Name DOB
PATIENT TREATMENT AGREEMENT
PATIENT TREATMENT AGREEMENT Patient Name: : As a participant in buprenorphine treatment for opioid misuse and dependence, I freely and voluntarily agree to accept this treatment agreement as follows: I
More informationArkansas Emergency Department Opioid Prescribing Guidelines
Arkansas Emergency Department Opioid Prescribing Guidelines 1. One medical provider should provide all opioids to treat a patient s chronic pain. 2. The administration of intravenous and intramuscular
More informationALPHA RECOVERY CENTERS Application & Screening Data
ALPHA RECOVERY CENTERS Application & Screening Data I am applying for admission to: Alpha Recovery Centers Atlanta Alpha Recovery Centers - Brunswick Thank you for your interest in Alpha Recovery Centers.
More informationSUBOXONE /VIVITROL WEBINAR. Educational Training tool concerning the Non-Methadone Medication Assisted Treatment Policy that is Effective on 1/1/12
SUBOXONE /VIVITROL WEBINAR Educational Training tool concerning the Non-Methadone Medication Assisted Treatment Policy that is Effective on 1/1/12 WEBINAR INTRODUCTIONS Cynthia Parsons- Program Manager
More informationOpioid Agreement for Center for Pain Management S.C.
Opioid Agreement for Center for Pain Management S.C. Patient Name: DOB: I am the patient named above. I have agreed to use pain medication as part of my treatment for chronic pain. I understand that these
More information2015 OPSC Annual Convention. syllabus. February 4-8, 2015 Hyatt Regency Mission Bay San Diego, California
2015 OPSC Annual Convention syllabus February 4-8, 2015 Hyatt Regency Mission Bay San Diego, California FRIDAY, FEBRUARY 6, 2015: 9:30am - 10:30am Opioid Addiction and Buprenorphine Use * Presented by
More informationDiscontinuation: Involuntary Discharge
Discontinuation: Involuntary Discharge TYPICALLY A PROCESS NOT AN EVENT Objectives 2 Review indications for discharge. Develop a therapeutic approach, in the context of the nature of Substance Use Disorders.
More informationPain, Addiction & Methadone
Pain, Addiction & Methadone A CHALLENGING INTERFACE METHADONE AND SUBOXONE OPIOID SUBSTITUTION CONFERENCE Objectives 2 Explore the interface between concurrent pain and addiction. Appreciate the challenges
More informationGetting the best result from Opioid medicine. in the management of chronic pain
Getting the best result from Opioid medicine in the management of chronic pain Your doctor has prescribed you opioid medicine to help you manage your chronic pain. This patient information leaflet gives
More informationBuprenorphine/Naloxone Maintenance Treatment for Opioid Dependence
Buprenorphine/Naloxone Maintenance Treatment for Opioid Dependence Information for Family Members Family members of patients who have been prescribed buprenorphine/naloxone for treatment of opioid addiction
More informationMagee-Womens Hospital
Magee-Womens Hospital Magee Pregnancy Recovery Program: History Pregnancy Recovery Center A Medical Home Model Approach to Strengthen Families Bawn Maguire, MSN, RN Programmatic Nurse Specialist Stephanie
More informationAn integrated approach to addressing opiate abuse in Maine. Debra L. Brucker, MPA, PhD State of Maine Office of Substance Abuse October 2009
An integrated approach to addressing opiate abuse in Maine Debra L. Brucker, MPA, PhD State of Maine Office of Substance Abuse October 2009 Background Defining the problem: Opiates pain relievers (OxyContin,
More information5317 Cherry Lawn Rd, Huntington, WV 25705 Phone: (304) 302-2078 Fax: (304) 302-0279. Welcome
5317 Cherry Lawn Rd, Huntington, WV 25705 Phone: (304) 302-2078 Fax: (304) 302-0279 Welcome Welcome to Starlight Behavioral Health Opiate Dependence program. At Starlight, we believe that addiction is
More informationSample Patient Agreement Forms
Sample Patient Agreement Forms Introduction This resource includes two sample patient agreement forms that can be used with patients who are beginning long-term treatment with opioid analgesics or other
More informationInformation for Pharmacists
Page 43 by 42 CFR part 2. A general authorization for the release of medical or other information is NOT sufficient for this purpose. Information for Pharmacists SUBOXONE (buprenorphine HCl/naloxone HCl
More informationUrine Drug Testing Methadone 101 Methadone for hospitalists
Urine Drug Testing Methadone 101 Methadone for hospitalists Dr. Patricia Mark MB, BCh LEARNING OBJECTIVES Clarify the purpose of urine drug testing Distinguish between UDT for detection of illicit drug
More information3.1. The procedure shall be applicable to all University employees.
LINCOLN UNIVERSITY Procedure: Confirmatory Testing for Substance Abuse Procedure Number: HRM 113p Effective Date: October 2008 Revisions: Review Officer: Chief Human Resources Officer 1. Purpose 1.1. It
More informationMassachusetts Substance Abuse Policy and Practices. Senator Jennifer L. Flanagan Massachusetts Worcester and Middlesex District
Massachusetts Substance Abuse Policy and Practices Senator Jennifer L. Flanagan Massachusetts Worcester and Middlesex District November 2014 Substance Abuse and Addiction National and State opioid abuse
More informationDrug Testing to Support Pain Management
NATIONAL REFERENCE LABORATORY Drug Testing to Support Pain Management 500 Chipeta Way, Salt Lake City, UT 84108 (800) 522-2787 (801) 583-2787 www.aruplab.com www.arupconsult.com ARUP is an enterprise of
More informationFrequently asked questions
Naltrexone Pellet Treatment for Opiate, Heroin, and Alcohol Addiction Frequently asked questions What is Naltrexone? Naltrexone is a prescription drug that completely blocks the effects of all opioid drugs
More informationOpioid Contracts: A Tool for Providing Relief and Preventing Abuse?
Opioid Contracts: A Tool for Providing Relief and Preventing Abuse? Jane Jurcic McMaster Family Practice and Hamilton Family Health Team Hamilton, Ontario Opioid Prescribing in Chronic Pain Legitimate
More informationMEDWAY SCHOOL BOARD POLICY DRUG AND ALCOHOL TESTING OF SCHOOL BUS DRIVERS
MEDWAY SCHOOL BOARD POLICY DRUG AND ALCOHOL TESTING OF SCHOOL BUS DRIVERS NEPN/NSBA CODE: EEAEAA The safety of our students, employees and the general public requires that our drivers perform their duties
More informationTestimony Engrossed House Bill 1101 Department of Human Services Senate Human Services Committee Senator Judy Lee, Chairman February 19, 2013
Testimony Engrossed House Bill 1101 Department of Human Services Senate Human Services Committee Senator Judy Lee, Chairman February 19, 2013 Chairman Lee, members of the Senate Human Services Committee,
More informationFrequently Asked Questions (FAQ s): Medication-Assisted Treatment for Opiate Addiction
Frequently Asked Questions (FAQ s): Medication-Assisted Treatment for Opiate Addiction March 3, 2008 By: David Rinaldo, Ph.D., Managing Partner, The Avisa Group In this FAQ What medications are currently
More informationNaltrexone Pellet Treatment for Opiate, Heroin, and Alcohol Addiction. Frequently Asked Questions
Naltrexone Pellet Treatment for Opiate, Heroin, and Alcohol Addiction Frequently Asked Questions What is Naltrexone? Naltrexone is a prescription drug that effectively blocks the effects of heroin, alcohol,
More informationD.O.T. (DEPARTMENT OF TRANSPORTATION) DRUG AND ALCOHOL TESTING POLICY
D.O.T. (DEPARTMENT OF TRANSPORTATION) DRUG AND ALCOHOL TESTING POLICY Purpose: Anoka-Hennepin School District #11 realizes the importance of providing a safe and healthy work place and minimizing the risks
More informationEPIDEMIC 4.6 % OF INDIVIDUALS 18 25 USED PAIN RELIEVERS FOR NON-MEDICAL REASONS. 1.5 MILLION YOUNG ADULTS USED PAIN RELIEVERS IN THE PAST MONTH.
Drug Court EPIDEMIC In the 10 years (1997 2007) the per capita retail purchases of Methadone, Hydrocodone and Oxycodone in the United States increased 13-fold, 4-fold and 9-fold, respectively. 4.6 % OF
More informationMAT Disclosures & Consents 1 of 6. Authorization & Disclosure
MAT Disclosures & Consents 1 of 6 Authorization & Disclosure ***YOUR INSURANCE MAY NOT PAY FOR ROUTINE SCREENING*** *** APPROPRIATE SCREENING DIAGNOSES MUST BE PROVIDED WHEN INDICATED*** Urine Drug Test
More informationAfter seeing a patient on a Diversion Alert installment..
After seeing a patient on a Diversion Alert installment.. Recommendations from Dr. James Berry of Mercy Recovery Center OVERVIEW OF DIVERSION Manufacture Distribution Pharmacy Patient End -user OPPORTUNITIES
More informationopiates alcohol 27 opiates and alcohol 30 April 2016 drug addiction signs 42 Ranked #1 123 Drug Rehab Centers in New Jersey 100 Top 10 380
opiates alcohol 27 opiates and alcohol 30 April 2016 drug addiction signs 42 ed #1 123 Drug Rehab Centers in New Jersey 100 Top 10 380 effects of alcohol in the brain 100 Top 30 698 heroin addiction 100
More informationDrug and Alcohol Testing for Bus Drivers
Drug and Alcohol Testing for Bus Drivers School bus drivers who operate a motor vehicle requiring a commercial driver's license are subject to a drug and alcohol testing program that fulfills the requirements
More informationSCOTTISH PRISON SERVICE DRUG MISUSE AND DEPENDENCE OPERATIONAL GUIDANCE
SCOTTISH PRISON SERVICE DRUG MISUSE AND DEPENDENCE OPERATIONAL GUIDANCE 1 P a g e The following Operational Guidance Manual has been prepared with input from both community and prison addictions specialists
More informationPRESCRIPTION PAINKILLER OVERDOSES
IMPACT{ POLICY PRESCRIPTION PAINKILLER OVERDOSES National Center for Injury Prevention and Control Division of Unintentional Injury Prevention What s the Issue? In a period of nine months, a tiny Kentucky
More informationARCHIVED BULLETIN. Product No. 2004-L0424-013 SEPTEMBER 2004 U. S. D E P A R T M E N T O F J U S T I C E
BULLETIN INTELLIGENCE Product No. 2004-L0424-013 SEPTEMBER 2004 U. S. D E P A R T M E N T O F J U S T I C E NDIC Within the past 2 years buprenorphine a Schedule III drug has been made available for use
More informationMEDICAL ASSISTANCE BULLETIN
ISSUE DATE September 4, 2015 SUBJECT EFFECTIVE DATE September 9, 2015 MEDICAL ASSISTANCE BULLETIN NUMBER *See below BY Prior Authorization of Opiate Dependence Treatments, Oral Buprenorphine Agents - Pharmacy
More informationAppendix to Tennessee Department of Health: Tennessee Clinical Practice Guidelines for Outpatient Management of Chronic Non- Malignant Pain
Appendix to Tennessee Department of Health: Tennessee Clinical Practice Guidelines for Outpatient Management of Chronic Non- Malignant Pain Division of Workers Compensation 04.01.2015 Background Opioids
More informationUnderstanding Medication Assisted Treatment (MAT) for Families Affected by Substance Use Disorders
Understanding Medication Assisted Treatment (MAT) for Families Affected by Substance Use Disorders March 20, 2013 Pamela Petersen- Baston, MPA, CAP, CPP 4 9 4 0 I r v i n e B l v d., S u i t e 2 0 2 I
More informationSAMHSA Initiatives to Educate Prescribers and Consumers and Treatment Resources
SAMHSA Initiatives to Educate Prescribers and Consumers and Treatment Resources Nick Reuter Division of Pharmacologic Therapy Substance Abuse and Mental Health Services Administration 1 Overview National
More informationMEDICAL ASSISTANCE BULLETIN
ISSUE DATE SUBJECT EFFECTIVE DATE MEDICAL ASSISTANCE BULLETIN NUMBER *See below BY Prior Authorization of Opiate Dependence Treatments Pharmacy Service Leesa M. Allen, Deputy Secretary Office of Medical
More informationJane Maxwell, UT Addiction Research Institute, 512 232-0610. Prescription Pain Medications and Heroin: A Changing Picture
Prescription Pain Medications and : A Changing Picture Jane Maxwell, Ph.D. Center for Social Work Research The University of Texas at Austin Disclosure to Participants Commercial Support: This educational
More informationOpioid/Opiate Dependent Pregnant Women
Opioid/Opiate Dependent Pregnant Women The epidemic, safety, stigma, and how to help. Presented by Lisa Ramirez MA,LCDC & Kerby Stewart MD The prescription painkiller epidemic is killing more women than
More informationSAFE PAIN MEDICATION PRESCRIBING GUIDELINES
Prescription drug abuse has been declared an epidemic by the Centers for Disease Control. According to 2012 San Diego Medical Examiner data, the number one cause of non-natural death is due to drug overdoses
More informationVisit www.takebackmylife.org to hear more of my story or call 211 for help and treatment options
In high school, I experimented with alcohol and pot. Then I moved on to narcotics and cocaine, which landed me in jail several times. By 25, I was a daily heroin user with a long-term prison sentence.
More informationST. CLAIR COUNTY COMMUNITY MENTAL HEALTH Date Issued: 07/09 Date Revised: 09/11;03/13;06/14;07/15
ST. CLAIR COUNTY COMMUNITY MENTAL HEALTH Date Issued: 07/09 Date Revised: 09/11;/13;06/14;07/15 WRITTEN BY Jim Johnson Page 1 REVISED BY AUTHORIZED BY Jessica Moeller Debra Johnson I. APPLICATION: THUMB
More informationPolicy on Opioid Drugs for Non-Cancer Pain and Patient Medication Agreement
Policy on Opioid Drugs for Non-Cancer Pain and Patient Medication Agreement I understand that I have apain problem that has failed to respond to other treatments. It is recommended that I begin or continue
More informationINFO Brief. Prescription Opioid Use: Pain Management and Drug Abuse In King County and Washington State
ADAI-IB 23-3 INFO Brief Prescription Opioid Use: Pain Management and Drug Abuse In King County and Washington State O ctober 23 Caleb Banta-Green (Alcohol and Drug Abuse Institute, University of Washington),
More informationTRENDS IN HEROIN USE IN THE UNITED STATES: 2002 TO 2013
2013 to 2002 States: United the in Use Heroin in Trends National Survey on Drug Use and Health Short Report April 23, 2015 TRENDS IN HEROIN USE IN THE UNITED STATES: 2002 TO 2013 AUTHORS Rachel N. Lipari,
More informationOpioid overdose can occur when a patient misunderstands the directions
Facts About Opioid Overdose How Does an Overdose Occur? Opioid overdose can occur when a patient misunderstands the directions for use, accidentally takes an extra dose, or deliberately misuses a prescription
More informationKENTUCKY ADMINISTRATIVE REGULATIONS TITLE 201. GENERAL GOVERNMENT CABINET CHAPTER 9. BOARD OF MEDICAL LICENSURE
KENTUCKY ADMINISTRATIVE REGULATIONS TITLE 201. GENERAL GOVERNMENT CABINET CHAPTER 9. BOARD OF MEDICAL LICENSURE 201 KAR 9:260. Professional standards for prescribing and dispensing controlled substances.
More informationName: Date of Birth: Social Security #: Home # Cell # Address: City: State: Zip: Emergency Contact #: Relationship:
California Back and Pain Specialists 14624 Sherman Way, Suite 309, Van Nuys, CA 91405 1172 Swallow Lane, Simi Valley, CA 93065 101 Hodencamp Road, Suite 103, Thousand Oaks, CA 91360 9201 Sunset Blvd, Suite
More informationThe ABCs of Medication Assisted Treatment
The ABCs of Medication Assisted Treatment J E F F R E Y Q U A M M E, E X E C U T I V E D I R E C T O R C O N N E C T I C U T C E R T I F I C A T I O N B O A R D The ABCs of Medication Assisted Treatment
More informationKnowing the Facts About Medication Adherence Among Those with Serious Mental Illness
FALL 2015 VOLUME #01 IN G E N UI TY HE A LTH : PRESCRIPTION DRUG REPORT A Review of Medication Monitoring Results of People in Treatment for Serious Mental Illness Knowing the Facts About Medication Adherence
More informationSOUTH CAROLINA DEPARTMENT OF ADMINISTRATION DRUG AND ALCOHOL TESTING POLICY AND PROCEDURE
SOUTH CAROLINA DEPARTMENT OF ADMINISTRATION DRUG AND ALCOHOL TESTING POLICY AND PROCEDURE THE LANGUAGE USED IN THIS DOCUMENT DOES NOT CREATE AN EMPLOYMENT CONTRACT BETWEEN THE EMPLOYEE AND THE AGENCY.
More informationDeath in the Suburbs: How Prescription Painkillers and Heroin Have Changed Treatment and Recovery
Death in the Suburbs: How Prescription Painkillers and Heroin Have Changed Treatment and Recovery Marvin D. Seppala, MD Chief Medical Officer Hazelden Betty Ford Foundation This product is supported by
More informationManaging Chronic Pain in Adults with Substance Use Disorders
Question from chapter 1 Managing Chronic Pain in Adults with Substance Use Disorders 1) What is the percent of chronic pain patients who may have addictive disorders? a) 12% b) 22% c) 32% d) 42% 2) Which
More informationPresentation to Senate Health and Human Services Committee: Prescription Drug Abuse in Texas
Presentation to Senate Health and Human Services Committee: Prescription Drug Abuse in Texas David Lakey, MD Commissioner, Department of State Health Services Lauren Lacefield Lewis Assistant Commissioner,
More informationOpiates Heroin/Prescription Steve Hanson Opiates Dates to 4,000 BC Mimics endorphin activity Natural - Opium, morphine, codeine Semi-synthetic- Heroin, Dilaudid Synthetics - Darvon, Demerol, Fentanyl Modern
More informationDrug Abuse & Alcoholism
Drug Abuse & Alcoholism PRESENTED BY: ROBERT SWOTINSKY M D FOR MEDICAL EXAMINER COURSE 978-337-4479 P SWOTINSKY@COMCAST.NET Drugs, Drinking, and Driving CMV drivers - more fatalities than any other occupation.
More informationPrescription drug abuse trends. Minnesota s Prescription Monitoring Program. Minnesota Rural Health Conference June 25, 2013 Duluth
Prescription drug abuse trends Minnesota s Prescription Monitoring Program Carol Falkowski Drug Abuse Dialogues www.drugabusedialogues.com Barbara Carter, Manager MN Board of Pharmacy www.pmp.pharmacy.state.mn.us
More informationPARTNERSHIP HEALTHPLAN RECOMMENDATIONS For Safe Use of Opioid Medications
PARTNERSHIP HEALTHPLAN RECOMMENDATIONS For Safe Use of Opioid Medications Primary Care & Specialist Prescribing Guidelines Introduction Partnership HealthPlan is a County Organized Health System covering
More informationAppendices to Interim Report on the Baltimore Buprenorphine Initiative. Managed Care Organization Information Pages
Appendices to Interim Report on the Baltimore Buprenorphine Initiative Appendix A Managed Care Organization Information Pages Appendix B Buprenorphine Online Physician Training Information Packet Appendix
More information2015 REPORT Steven W. Schierholt, Esq. Executive Director www.pharmacy.ohio.gov
OHIO AUTOMATED RX REPORTING SYSTEM 2015 REPORT Steven W. Schierholt, Esq. Executive Director www.pharmacy.ohio.gov OHIO AUTOMATED RX REPORTING SYSTEM What is OARRS? To address the growing misuse and diversion
More informationPrescription Drug Abuse and NASPER Harold Rogers Prescription Drug Monitoring Program June 30, 2010 Washington, DC
Prescription Drug Abuse and NASPER Harold Rogers Prescription Drug Monitoring Program June 30, 2010 Washington, DC Nick Reuter Division of Pharmacologic Therapy Substance Abuse and Mental Health Services
More informationTENNESSEE BOARD OF MEDICAL EXAMINERS POLICY STATEMENT OFFICE-BASED TREATMENT OF OPIOID ADDICTION
TENNESSEE BOARD OF MEDICAL EXAMINERS POLICY STATEMENT OFFICE-BASED TREATMENT OF OPIOID ADDICTION The Tennessee Board of Medical Examiners has reviewed the Model Policy Guidelines for Opioid Addiction Treatment
More informationAsset Marketing Services, Inc. Drug and Alcohol Testing Policy (MN)
Drug and Alcohol Use Asset Marketing Services, Inc. Drug and Alcohol Testing Policy (MN) Illegal drug use in the workplace is against the law and highly detrimental to the safety and productivity of our
More informationDrug overdose death rates by state per 100,000 people (2008) SOURCE: National Vital Statistics System, 2008
PRESCRITPION DRUG ABUSE: AN EPIDEMIC What is Addiction? By: Lon R. Hays, M.D., M.B.A. Professor and Chairman Department of Psychiatry University of Kentucky Healthcare Addiction is a primary, chronic disease
More informationPain and problem drug use
Pain and problem drug use Information for patients Prepared by the British Pain Society in consultation with the Royal College of Psychiatrists, the Royal College of General Practitioners and the Advisory
More informationHow To Get A Prescription In Rhode Island
Controlled Substance Prescribing Laws, The Prescription Monitoring Program, and Preventing Drug Diversion Michael Halse, PharmD PGY1 Resident Pharmacist South County Hospital and Healthcare System Disclosures
More informationGuidelines for Cancer Pain Management in Substance Misusers Dr Jane Neerkin, Dr Chi-Chi Cheung and Dr Caroline Stirling
Guidelines for Cancer Pain Management in Substance Misusers Dr Jane Neerkin, Dr Chi-Chi Cheung and Dr Caroline Stirling Patients with a substance misuse history are at increased risk of receiving inadequate
More informationTULSA COMMUNITY COLLEGE HEALTH SCIENCES STUDENT GUIDELINES: DRUG SCREENING PROCEDURES
TULSA COMMUNITY COLLEGE HEALTH SCIENCES STUDENT GUIDELINES: DRUG SCREENING PROCEDURES I. SCOPE & PURPOSE Drug screening will be performed on all students of TCC Health Sciences programs prior to their
More informationTriage, Assessment & Treatment Methadone 101/Hospitalist Workshop
Triage, Assessment & Treatment Methadone 101/Hospitalist Workshop Launette Rieb, MSc, MD, CCFP, FCFP Clinical Associate Professor, Dept. Family Practice UBC American Board of Addiction Medicine Certified
More informationPrescription Drug Abuse: Recognition, Intervention, and Prevention
Prescription Drug Abuse: Recognition, Intervention, and Prevention Nicholas Reuter Division of Pharmacologic Therapy Center for Substance Abuse Treatment Substance Abuse and Mental Health Services Administration
More information2.2 Keeping Patients Safe: A Case Study on Using Prescription Monitoring Program Data in an Outpatient Addictions Treatment Setting
Prescription Monitoring Program Center of Excellence Notes from the Field 2.2 Keeping Patients Safe: A Case Study on Using Prescription Monitoring Program Data in an Outpatient Addictions Treatment Setting
More informationPOLICY FOR A DRUG AND ALCOHOL-FREE WORKPLACE
POLICY FOR A DRUG AND ALCOHOL-FREE WORKPLACE I. STATEMENT OF PURPOSE Crossroads of Western Iowa recognizes the problems of substance abuse in society and in the workplace. Substance abuse poses a serious
More informationPRESCRIPTION DRUG ABUSE: THE NATIONAL PERSPECTIVE
PRESCRIPTION DRUG ABUSE: THE NATIONAL PERSPECTIVE May 19, 2012 National Association Boards of Pharmacy Annual Meeting Gil Kerlikowske, Director White House Office of National Drug Control Policy ONDCP
More informationCONTROLLED SUBSTANCE CONTRACT
CONTROLLED SUBSTANCE CONTRACT The purpose of this contract is to protect my access to controlled substances and to protect our ability to prescribe for you. The long-term use of substances such as opiates
More informationThe prevalence of use of psychotropic drugs, buprenorphine and methadone on the streets, the polyuse of substances in Finland
The prevalence of use of psychotropic drugs, buprenorphine and methadone on the streets, the polyuse of substances in Finland Hannu Alho, Professor Unit on Prevention and Treatment of Addictions, National
More informationPOLICY TITLE: Bus Driver Drug and Alcohol POLICY NO: 744 POLICY TITLE: Testing Program PAGE 1 of 8
POLICY TITLE: Bus Driver Drug and Alcohol POLICY NO: 744 POLICY TITLE: Testing Program PAGE 1 of 8 This school district has an interest in establishing a work environment free from the influence of drugs
More informationDependence and Addiction. Marek C. Chawarski, Ph.D. Yale University David Metzger, Ph.D. University of Pennsylvania
Dependence and Addiction Marek C. Chawarski, Ph.D. Yale University David Metzger, Ph.D. University of Pennsylvania Overview Heroin and other opiates The disease of heroin addiction or dependence Effective
More informationEEAEAA - DRUG AND ALCOHOL USE BY AND TESTING FOR DRIVERS WITH A COMMERCIAL DRIVER S LICENSE (CDL)
EEAEAA - DRUG AND ALCOHOL USE BY AND TESTING FOR DRIVERS WITH A COMMERCIAL DRIVER S LICENSE (CDL) APPLICABILITY In accordance with federal law and regulations, all bus operators and other District drivers
More informationMaryland Medicaid HealthChoice Substance Use Disorder Form Instructions
Maryland Medicaid HealthChoice Substance Use Disorder Form Instructions Form Instructions for the following Community-Based Substance Use Disorder Services: Individual Outpatient Therapy, Group Outpatient
More informationIN THE GENERAL ASSEMBLY STATE OF. Ensuring Access to Medication Assisted Treatment Act
IN THE GENERAL ASSEMBLY STATE OF Ensuring Access to Medication Assisted Treatment Act 1 Be it enacted by the People of the State of Assembly:, represented in the General 1 1 1 1 Section 1. Title. This
More informationOpioid Treatment Agreement
Opioid Treatment Agreement 1. I understand that my provider and I will work together to find the most appropriate treatment for my chronic pain. I understand the goals of treatment are not to eliminate
More informationOPIOID PAIN MEDICATION Agreement and Informed Consent
OPIOID PAIN MEDICATION Agreement and Informed Consent I. Introduction Research and clinical experience show that opioid (narcotic) pain medications are helpful for some patients with chronic pain. The
More informationINSTRUCTIONS AND PROTOCOLS FOR THE IMPLEMENTATION OF MEDICATION-ASSISTED TREATMENT FOR OPIOID/OPIATE DEPENDENCE
201 Mulholland Bay City, MI 48708 P 989-497-1344 F 989-497-1348 www.riverhaven-ca.org Title: MAT Protocol Original Date: March 30, 2009 Latest Revision Date: December 16, 2013 Approval/Release Date: January
More informationMedical Malpractice Treatment Alprazolam benzodiazepine - A Case Study
Improving Outcomes in Patients Who are Prescribed Alprazolam with Concurrent Use of Opioids Pik-Sai Yung, M.D. Staff Psychiatrist Center for Counseling at Walton Background and Rationale Alprazolam is
More informationHow To Understand The Health Effects Of Prescription Drugs
Miami-Dade, Broward and Palm Beach Counties, Florida Trends of Nonmedical Prescription Drug Misuse in Miami-Dade, Broward, Palm Beach Counties, and the State of Florida: 2010 James N. Hall 1 ABSTRACT The
More informationOverall Learning Objectives
Overall Learning Objectives Understand the difference between use, misuse and abuse of substances/drugs; Differentiate between commonly abused legal and illegal substances/drugs; Become aware of common
More informationMEDICAID DRUG SPENDING ON ANTI- ADDICTION MEDICATION AND OPIOID ADDICTION REFRESHER
MEDICAID DRUG SPENDING ON ANTI- ADDICTION MEDICATION AND OPIOID ADDICTION REFRESHER TWO PRIMARY ACCESS POINTS Pharmacy Benefit Dispensed by a Pharmacy Billed via the PBM Process (NCPCP) Oversight by Drug
More informationPractice Protocol. Buprenorphine Guidance Protocol
Practice Protocol Buprenorphine Guidance Protocol Developed by the Arizona Department of Health Services Division of Behavioral Health Services Effective Date: 02/23/11 Title Buprenorphine Guidance Protocol
More informationThe TIRF REMS Access program is a Food and Drug Administration (FDA) required risk management program
Subject: Important Drug Warning Announcement of a single shared REMS (Risk Evaluation and Mitigation Strategy) program for all Transmucosal Immediate Release Fentanyl (TIRF) products due to the potential
More informationEver wish you could... Quit using heroin? Protect yourself from HIV infection? Get healthier?
Ever wish you could... Quit using heroin? Protect yourself from HIV infection? Get healthier? Good News: Medical treatments called opioid (oh-pee-oyd) maintenance can help you! Injecting heroin puts you
More informationOutcomes for Opiate Users at FRN Facilities. FRN Research Report September 2014
Outcomes for Opiate Users at FRN Facilities FRN Research Report September 2014 Introduction The illicit use of opioids has reached epidemic proportions in the United States (Alford, 2007; Meges et al,
More informationUPDATE FORM 2011. Name: (First) (Last) (Middle Initial) Address: Home Phone: Work/Other Phone. Social Security #: Date of Birth:
COMPREHENSIVE PSYCHIATRIC CARE Psychopharmacology & Psychotherapy Adults, Adolescents, Children & Seniors UPDATE FORM 2011 Please fill out this form completely (front and back) Name: (First) (Last) (Middle
More informationOpioid Overdose Prevention for Law Enforcement and First Responders. Sponsored by the NC Office of EMS
Opioid Overdose Prevention for Law Enforcement and First Responders Sponsored by the NC Office of EMS Overview The goal of this presentation is to help inform the public safety community of North Carolina
More information(Updated: 10/12/2015)
DRUG TESTING & BACKGROUND CHECK Pfizer s Drug Testing and Background Check Requirements for Contingent Workers and Suppliers, Including Criminal and MVR Record Checks, FDA Debarment Database and DEA Controlled
More informationMedication treatments for opioid use disorders
Medication treatments for opioid use disorders Summary for counties JUDITH MARTIN, Medical Director of Substance Use Services, San Francisco Department of Public Health Brief history of Methadone and Buprenorphine
More informationVIRGINIA S PRESCRIPTION MONITORING PROGRAM
VIRGINIA S PRESCRIPTION MONITORING PROGRAM A Resource for Patient Management with Controlled Substances 2,500 Past Year Initiates of Specific Illicit Drugs among Persons Aged 12 or Older: 2009 Numbers
More informationOpiate Addiction in Ohio: An Update on Scope of Problem Ashland Ohio
Governor s Cabinet Opiate Action Team Promoting Wellness and Recovery John R. Kasich, Governor Tracy J. Plouck, Director Opiate Addiction in Ohio: An Update on Scope of Problem Ashland Ohio November 14,
More informationProvider enews TREATING PRESCRIPTION DRUG ADDICTION
Provider enews TREATING PRESCRIPTION DRUG ADDICTION Treating addiction to prescription opioids July 2012 Several options are available for effectively treating prescription opioid addiction. These options
More information